阿莫西林不同给药方案对根除幽门螺杆菌疗效的影响(4)
[13] Malfertheiner P,Megraud F,O′Morain CA,et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report [J]. Gut,2017,66(1):6-30.
[14] 劉文忠,谢勇,陆红,等.第五次全国幽门螺杆菌感染处理共识报告[J].胃肠病学,2017,22(6):346-360.
[15] Venerito M,Krieger T,Ecker T,et al. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection [J]. Digestion,2013,88(1):33-45.
[16] 刘文忠.努力提高幽门螺杆菌根除率(一)[J].胃肠病学,2016,21(8):450-454.
[17] 王淑君,王蔚虹,褚云香,等.不含铋剂四联疗法与标准 三联疗法根除幽门螺杆菌的效果分析[J].中华医学杂志,2014,94(8):576-579.
[18] 姚伟,王天琳,李晶.临床药师服务能力建设探讨[J].中国医院,2018,22(3):60-62.
[19] 陶河清,闫秀娥.幽门螺杆菌根除后继发难辨梭状芽孢杆菌感染一例报道并文献复习[J].中国全科医学,2017, 20(30):3807-3810.
[20] Furuta T,Sugimoto M,Kodaira C,et al. The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori [J]. Hepatogastroenterology,2010,57:1314-1319., 百拇医药(罗宜辉 刘代华)
[14] 劉文忠,谢勇,陆红,等.第五次全国幽门螺杆菌感染处理共识报告[J].胃肠病学,2017,22(6):346-360.
[15] Venerito M,Krieger T,Ecker T,et al. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection [J]. Digestion,2013,88(1):33-45.
[16] 刘文忠.努力提高幽门螺杆菌根除率(一)[J].胃肠病学,2016,21(8):450-454.
[17] 王淑君,王蔚虹,褚云香,等.不含铋剂四联疗法与标准 三联疗法根除幽门螺杆菌的效果分析[J].中华医学杂志,2014,94(8):576-579.
[18] 姚伟,王天琳,李晶.临床药师服务能力建设探讨[J].中国医院,2018,22(3):60-62.
[19] 陶河清,闫秀娥.幽门螺杆菌根除后继发难辨梭状芽孢杆菌感染一例报道并文献复习[J].中国全科医学,2017, 20(30):3807-3810.
[20] Furuta T,Sugimoto M,Kodaira C,et al. The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori [J]. Hepatogastroenterology,2010,57:1314-1319., 百拇医药(罗宜辉 刘代华)